back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-24 16:41 Tx date 2024-09-20 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,800
+20,000 vol $0.09 each |
323,492 | |
| Filed 2024-08-07 12:25 Tx date 2024-08-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+225,000 vol |
225,000 | |
| Filed 2024-08-07 12:24 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-08-07 12:22 Tx date 2024-08-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$27,000
+225,000 vol $0.12 each |
745,000 | |
| Filed 2024-06-24 15:07 Tx date 2024-06-20 |
$WAVE
WAVERLEY PHARMA INC. |
Kinley, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
56,500 | ||
| Filed 2024-05-21 12:05 Tx date 2024-05-16 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,562
+12,500 vol $0.125 each |
303,492 | |
| Filed 2024-02-02 14:05 Tx date 2024-01-30 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Rights RSUs
56 - Grant of rights
|
+400,000 vol |
400,000 | |
| Filed 2024-02-02 14:03 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-04 16:24 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$7,800
+120,000 vol $0.065 each |
120,000 | |
| Filed 2024-01-04 16:23 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-04 16:22 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-120,000 vol |
0 | |
| Filed 2023-12-28 14:04 Tx date 2023-12-27 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+280,000 vol |
285,496 | |
| Filed 2023-12-28 14:02 Tx date 2023-12-27 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$21,000
+280,000 vol $0.075 each |
290,992 | |
| Filed 2023-05-09 13:18 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
$-1,374
-5,496 vol $0.25 each |
0 | |
| Filed 2023-05-09 13:16 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
$2,857
+5,496 vol $0.52 each |
5,496 | |
| Filed 2023-05-09 13:15 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-09 13:09 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,374
+5,496 vol $0.25 each |
10,992 | |
| Filed 2023-04-18 14:19 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+5,496 vol |
5,496 | |
| Filed 2023-04-18 14:18 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-17 20:09 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+5,496 vol |
||
| Filed 2023-04-17 20:09 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+5,496 vol |
125,496 | |
| Filed 2023-03-13 15:27 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$41,512
+40,500 vol $1.02 each |
94,000 | |
| Filed 2023-03-13 15:26 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$40,425
+30,000 vol $1.35 each |
53,500 | |
| Filed 2023-03-13 15:24 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
37 - Stock split or consolidation
|
+90,000 vol |
120,000 | |
| Filed 2023-03-13 15:22 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+4,122 vol |
5,496 | |
| Filed 2023-02-03 12:12 Tx date 2023-02-01 |
$MPH
Medicure Inc. |
Kinley, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+60,000 vol $1.25 each |
60,000 | |
| Filed 2023-02-03 12:09 Tx date 2022-06-16 |
$MPH
Medicure Inc. |
Kinley, James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-05 18:03 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+30,000 vol |
30,000 | |
| Filed 2022-09-05 18:02 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-05 18:01 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$53,900
+10,000 vol $5.39 each |
23,500 | |
| Filed 2022-07-05 14:00 Tx date 2022-06-16 |
$MPH
Medicure Inc. |
Kinley, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
47,100 | ||
| Filed 2022-04-05 18:44 Tx date 2022-04-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,525
+250 vol $6.10 each |
1,374 | |
| Filed 2022-04-05 18:43 Tx date 2022-04-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,100
+500 vol $6.20 each |
1,124 | |
| Filed 2022-04-05 18:43 Tx date 2022-04-04 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$599.00
+100 vol $5.99 each |
624 | |
| Filed 2022-04-05 18:42 Tx date 2022-04-04 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+500 vol $6.00 each |
524 | |
| Filed 2022-01-20 13:10 Tx date 2022-01-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$55,349
+13,500 vol $4.10 each |
13,500 | |
| Filed 2022-01-20 13:08 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-30 18:07 Tx date 2021-12-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
24 | ||
| Filed 2018-06-08 Tx date 2018-06-08 |
$MPH
Medicure Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-13,500
-45,000 vol $0.30 each |
118,700 | |
| Filed 2018-06-08 Tx date 2018-06-08 |
$MPH
Medicure Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$13,500
+45,000 vol $0.30 each |
47,100 | |
| Filed 2017-12-22 Tx date 2017-12-19 |
$MPH
Medicure Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$720,000
+100,000 vol $7.20 each |
163,700 | |
| Filed 2016-04-11 Tx date 2016-04-06 |
$MPH
Medicure Inc. |
Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,640
+4,000 vol $6.16 each |
63,700 |